<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?DTDIdentifier.IdentifierValue article.dtd?>
  <?DTDIdentifier.IdentifierType system?>
  <?SourceDTD.DTDName article.dtd?>
  <?SourceDTD.Version 1.0?>
  <?ConverterInfo.XSLTName bmc2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Head Face Med</journal-id>
      <journal-title-group>
        <journal-title>Head &amp; Face Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-160X</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3115889</article-id>
      <article-id pub-id-type="publisher-id">1746-160X-7-9</article-id>
      <article-id pub-id-type="pmid">21569492</article-id>
      <article-id pub-id-type="doi">10.1186/1746-160X-7-9</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Clinico-pathological profile of head and neck malignancies at University College Hospital, Ibadan, Nigeria</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Adisa</surname>
            <given-names>Akinyele O</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>perakin80@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Adeyemi</surname>
            <given-names>Bukola F</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>oluwabukolawale2003@yahoo.com</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Oluwasola</surname>
            <given-names>Abideen O</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>oluwasol@yahoo.com</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Kolude</surname>
            <given-names>Bamidele</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>delekolude2003@yahoo.co.uk</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Akang</surname>
            <given-names>Effiong EU</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>eeakang@yahoo.com</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Lawoyin</surname>
            <given-names>Jonathan O</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>jonathanlawoyin@hotmail.com</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Departments of Oral Pathology University College Hospital, University of Ibadan, Ibadan, Oyo state, Nigeria</aff>
      <aff id="I2"><label>2</label>Department of Pathology, University College Hospital, University of Ibadan, Ibadan, Oyo state, Nigeria</aff>
      <pub-date pub-type="collection">
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <volume>7</volume>
      <fpage>9</fpage>
      <lpage>9</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>12</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>5</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2011 Adisa et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <copyright-holder>Adisa et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.head-face-med.com/content/7/1/9"/>
      <abstract>
        <sec>
          <title>Introduction</title>
          <p>This retrospective study analysed head and neck malignancies seen over a 19-year period at the University College Hospital, Ibadan.</p>
        </sec>
        <sec>
          <title>Methodology</title>
          <p>One thousand, one hundred and ninety two patients with head and neck malignancies were analysed according to age, gender, topography and histology.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>There was an annual hospital frequency of 62 cases per year. The overall mean age for these malignancies was 43.9 (SD &#xB1; 19.3) years. The lesions from the respiratory tract were the most frequent (43.2%) of all cases. The palate was the most frequent intra-oral site (13.8%). Epithelial malignancies constituted 73.4% of all cases with a male: female ratio of 2:1, a mean age of 48.1 (SD &#xB1; 17.5) years and were mostly located in the larynx (19.7%). Lymphomas constituted 17.5% of all head and neck cancers with a male: female ratio of 1.6:1, a mean age of 35.1 (SD &#xB1; 20.6) years and nodal involvement (39.7%) was most common. Sarcomas constituted 8.9% of all malignancies with a male: female ratio of 1.5:1, mean age of 27.1 (SD &#xB1; 16.7) years and the maxillofacial bones (42.5%) were most commonly involved. Neuroendocrine malignancies accounted for 0.2% of head and neck malignancies with a male: female ratio of 1:1, a mean age of 28.5 (SD &#xB1; 6.4) years and both cases involved the nose.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>This study has further confirmed that carcinomas remain the most frequent cancers of the head and neck region in south-western Nigeria.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>head and neck malignancies</kwd>
        <kwd>clinico-pathologic profile</kwd>
        <kwd>south-western Nigeria</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Head and neck cancers are malignant neoplasms occurring in the nasal cavities, paranasal sinuses, nasopharynx, hypopharnyx, oropharynx, ear, scalp, oral cavity and salivary glands [<xref ref-type="bibr" rid="B1">1</xref>]. These malignancies are associated with various aetiological factors such as tobacco and alcohol use [<xref ref-type="bibr" rid="B2">2</xref>], infection by oncogenic viruses, genetic factors and nutritional deficiency [<xref ref-type="bibr" rid="B3">3</xref>].</p>
      <p>Head and neck cancer is the tenth most common cancer in the world [<xref ref-type="bibr" rid="B4">4</xref>] and is an important cause of morbidity and mortality [<xref ref-type="bibr" rid="B5">5</xref>]. Patients with head and neck cancer have specific requirements that are beyond the needs of most other patients diagnosed with other types of cancer [<xref ref-type="bibr" rid="B6">6</xref>]. Several assorted histological types of tumours are found in the head and neck region. Between 70% to 90% of head and neck cancers are epithelial in origin, and squamous cell carcinoma constitutes 66.7% of carcinomas and 47.8% of all head and neck cancers [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. About 30% of all lymphomas occur in this region and they comprise the second most common primary malignancy in the head and neck region [<xref ref-type="bibr" rid="B9">9</xref>]. About 15% to 20% of all sarcomas are diagnosed in the head and neck region [<xref ref-type="bibr" rid="B10">10</xref>]. Osteogenic sarcoma, rhabdomyosarcoma, malignant fibrous histiocytoma and angiosarcoma are the most common histological types [<xref ref-type="bibr" rid="B11">11</xref>]. Salivary gland malignancies constitute about 1% of all head and neck cancer [<xref ref-type="bibr" rid="B7">7</xref>].</p>
      <p>The prospects of head and neck cancer depends on histological type, degree of histological differentiation of the tumour cells, clinical staging, primary site of tumour, age of patient, co-morbid conditions and neuro-vascular invasion [<xref ref-type="bibr" rid="B12">12</xref>]. The purpose of this study therefore is to estimate the importance of a clinico-pathological profile of head and neck malignancies in western Nigeria.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methodology</title>
      <p>This is a retrospective study that provides analysis of head and neck malignancies (with respect to age, gender, topography and histological diagnosis) at the University College Hospital (U.C.H.) Ibadan from January 1990 to December 2008. Local ethical clearance was obtained from the Joint University of Ibadan/University College Hospital Ethical Review Committee (registration number: NHREC/05/01/2008a).</p>
      <p>Biopsy report registers were obtained from the departments of Oral Pathology and Pathology U.C.H Ibadan and records of all malignant lesions involving the oral and nasal cavities, the paranasal sinuses, oropharynx, nasopharynx, hypopharynx, larynx, trachea, ear and salivary glands [<xref ref-type="bibr" rid="B1">1</xref>] were included. Malignancies involving the thyroid, eye and brain were excluded [<xref ref-type="bibr" rid="B1">1</xref>].</p>
      <p>The age grouping system used is that recommended for morbidity in health by the Department of International Economic and Social Affairs of the United Nations [<xref ref-type="bibr" rid="B13">13</xref>]. 1-14 years (children), 15-24 years (young adults or adolescents), 25-44 years (older adults), 45-64 years (middle aged), &#x2265;65 years (elderly).</p>
      <p>The data was entered into the version 16 of the Statistical Package for Social Sciences (SPSS16). Qualitative data were expressed as percentages and compared using chi-square statistics. Quantitative data were summarised using mean, standard deviation and confidence interval. The data were further compared using student t-test and/or one-way analysis of variance test as appropriate. The level of significance was set at p &lt; 0.05</p>
    </sec>
    <sec>
      <title>Results</title>
      <p>The hospital based prevalence was about 62 cases of malignant head and neck neoplasms per year. The time trend of relative frequencies during the period showed no regular pattern. However, none of the years recorded less than 40 patients (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Annual frequency of head and neck malignancies</bold>.</p>
        </caption>
        <graphic xlink:href="1746-160X-7-9-1"/>
      </fig>
      <sec>
        <title>Gender Distribution</title>
        <p>A total of 781 (65.5%) males and 410 (34.4%) females presented during the period under study [the gender of 1 person (0.1%) was not indicated in the record]. The overall approximate male to female ratio for malignant head and neck neoplasms was 1.9:1.</p>
      </sec>
      <sec>
        <title>Age Distribution</title>
        <p>The patients' ages ranged from 1 year to 98 years with a mean of 43.9 years (SD &#xB1; 19.3). There was no statistically significant difference between the mean ages of males and females (t = 1.145, df = 1187, p = 0.253). Head and neck malignancies occurred least frequently in the first decade of life and displayed a gradual increase until it peaked in the 45-64 age range (36.4% of cases) after which the incidence declined (Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>Age distribution of head and neck malignancies</bold>.</p>
          </caption>
          <graphic xlink:href="1746-160X-7-9-2"/>
        </fig>
      </sec>
      <sec>
        <title>Topography (general)</title>
        <p>The topographical distribution of the head and neck malignancies generally showed that lesions arising from the respiratory tract were the most frequent, accounting for 43.2% of the cases (Table <xref ref-type="table" rid="T1">1</xref>). These are lesions of the nose, nasopharynx, oropharynx, hypopharynx and larynx. Other less common sites included the maxillofacial bones (20.5%), oral cavity (12.5%) and cervical lymph nodes (11.2%).</p>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <p>Anatomical distribution of head and neck malignancies</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left">ANATOMICAL LOCATION</th>
                <th align="center">FREQUENCY</th>
                <th align="center">PERCENT</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">
                  <bold>Respiratory tract</bold>
                </td>
                <td align="center">
                  <bold>516</bold>
                </td>
                <td align="center">
                  <bold>43.2</bold>
                </td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Maxillofacial bones</bold>
                </td>
                <td align="center">
                  <bold>244</bold>
                </td>
                <td align="center">
                  <bold>20.5</bold>
                </td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Intraoral</bold>
                </td>
                <td align="center">
                  <bold>149</bold>
                </td>
                <td align="center">
                  <bold>12.5</bold>
                </td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Cervical lymph nodes</bold>
                </td>
                <td align="center">
                  <bold>133</bold>
                </td>
                <td align="center">
                  <bold>11.2</bold>
                </td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Salivary Glands</bold>
                </td>
                <td align="center">
                  <bold>64</bold>
                </td>
                <td align="center">
                  <bold>5.4</bold>
                </td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Face and scalp (soft tissue)</bold>
                </td>
                <td align="center">
                  <bold>63</bold>
                </td>
                <td align="center">
                  <bold>5.3</bold>
                </td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Ear</bold>
                </td>
                <td align="center">
                  <bold>16</bold>
                </td>
                <td align="center">
                  <bold>1.3</bold>
                </td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Oesophageal</bold>
                </td>
                <td align="center">
                  <bold>7</bold>
                </td>
                <td align="center">
                  <bold>0.6</bold>
                </td>
              </tr>
              <tr>
                <td align="left">
                  <bold>TOTAL</bold>
                </td>
                <td align="center">
                  <bold>1192</bold>
                </td>
                <td align="center">
                  <bold>100</bold>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><bold>*</bold>maxillofacial bones = maxilla, mandible, skull, maxillary sinus</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Topography of malignant maxillofacial tumours</title>
        <p>The maxilla (24.3%) represented the most frequent site of occurrence in the oro-facial complex, followed by the mandible (19.7%) and the salivary glands (13.9%), as shown in Table <xref ref-type="table" rid="T2">2</xref>. Intraorally, however the palate was found to be the most frequently affected.</p>
        <table-wrap id="T2" position="float">
          <label>Table 2</label>
          <caption>
            <p>Anatomical distribution of malignant maxillofacial tumours</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left">SITE</th>
                <th align="center">FREQUENCY</th>
                <th align="center">LOCAL PERCENTAGE</th>
                <th align="center">OVERALL PERCENTAGE</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">
                  <bold>Maxilla</bold>
                </td>
                <td align="center">105</td>
                <td align="center">24.2</td>
                <td align="center">8.8</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Mandible</bold>
                </td>
                <td align="center">85</td>
                <td align="center">19.6</td>
                <td align="center">7.1</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Salivary glands</bold>
                </td>
                <td align="center">60</td>
                <td align="center">13.9</td>
                <td align="center">5.0</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Palate</bold>
                </td>
                <td align="center">55</td>
                <td align="center">12.7</td>
                <td align="center">4.6</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Tonsil</bold>
                </td>
                <td align="center">26</td>
                <td align="center">6.0</td>
                <td align="center">2.2</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Cheek</bold>
                </td>
                <td align="center">25</td>
                <td align="center">5.8</td>
                <td align="center">2.1</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Tongue</bold>
                </td>
                <td align="center">25</td>
                <td align="center">5.8</td>
                <td align="center">2.1</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Floor of mouth</bold>
                </td>
                <td align="center">11</td>
                <td align="center">2.5</td>
                <td align="center">0.9</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Lip</bold>
                </td>
                <td align="center">9</td>
                <td align="center">2.1</td>
                <td align="center">0.8</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Face</bold>
                </td>
                <td align="center">32</td>
                <td align="center">7.4</td>
                <td align="center">2.7</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>TOTAL</bold>
                </td>
                <td align="center">433</td>
                <td align="center">100</td>
                <td/>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec>
        <title>Broad Histological Types</title>
        <p>The epithelial malignancies constituted 73.4% (875 patients) of all the cases (figure <xref ref-type="fig" rid="F3">3</xref>). Lymphomas and sarcomas constituted 17.5% and 8.9% of cases, respectively. There were two neuroendocrine tumours, accounting for 0.2% of the cases.</p>
        <fig id="F3" position="float">
          <label>Figure 3</label>
          <caption>
            <p><bold>Broad histological types of head and neck malignancies</bold>.</p>
          </caption>
          <graphic xlink:href="1746-160X-7-9-3"/>
        </fig>
      </sec>
      <sec>
        <title>Trends of the histological diagnosis</title>
        <p>Diagnosis of carcinomas exceeded (at least by a factor of 3) any other type of malignant lesion, every year consistently for 19 years. A sustained increase in the prevalence of carcinomas was also noted from 2002 to 2008, while lymphoma cases reduced comparatively from 2004 to 2007 (figure <xref ref-type="fig" rid="F4">4</xref>).</p>
        <fig id="F4" position="float">
          <label>Figure 4</label>
          <caption>
            <p><bold>Annual frequency of broad histological types of head and neck malignancies</bold>.</p>
          </caption>
          <graphic xlink:href="1746-160X-7-9-4"/>
        </fig>
      </sec>
      <sec>
        <title>Gender and age distribution within the broad histological types</title>
        <p>The male to female gender ratio for the broad histological types was 2:1 for carcinomas, 1.5: 1 for sarcomas, 1.6:1 for lymphomas and 1:1 for neuroendocrine tumours (table <xref ref-type="table" rid="T3">3</xref>).</p>
        <table-wrap id="T3" position="float">
          <label>Table 3</label>
          <caption>
            <p>Gender distribution of broad histological types of head and neck cancer</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th/>
                <th align="left">CARCINOMAS</th>
                <th align="left">SARCOMAS</th>
                <th align="left">LYMPHOMAS</th>
                <th align="left">NEUROENDOCRINE CARCINOMA</th>
                <th align="left">TOTAL</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">
                  <bold>MALE</bold>
                </td>
                <td align="left">586 (67.0%)</td>
                <td align="left">65 (61.3%)</td>
                <td align="left">129 (61.7%)</td>
                <td align="left">1 (50%)</td>
                <td align="left">781</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>FEMALE</bold>
                </td>
                <td align="left">288 (32.9%)</td>
                <td align="left">41 (38.7%)</td>
                <td align="left">80 (38.3%)</td>
                <td align="left">1 (50%)</td>
                <td align="left">410</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>MISSING</bold>
                </td>
                <td align="left">1 (0.1%)</td>
                <td/>
                <td/>
                <td/>
                <td align="left">1</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>TOTAL</bold>
                </td>
                <td align="left">875 (100%)</td>
                <td align="left">106 (100%)</td>
                <td align="left">209 (100%)</td>
                <td align="left">2 (100%)</td>
                <td align="left">1192</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Most cases of carcinomas were diagnosed in the 45-64 age group, with 361 (41.3%) patients (Table <xref ref-type="table" rid="T4">4</xref>). The sarcomas were most prevalent in the 25-44 years age range with 35 (33.0%) patients, closely followed by age group 15-24 years with 34 (32.1%) patients. A total of 85 head and neck malignancies were found in the age group 1-14 years with the most common lesion being lymphomas, which had 46 (54.1%) patients. Sarcomas were the second most common, consisting of 20 (23.5%) patients. Carcinomas accounted for 19 cases (22.3%), while there were no neuroendocrine tumours in the 1-14 year age group (Table <xref ref-type="table" rid="T4">4</xref>).</p>
        <table-wrap id="T4" position="float">
          <label>Table 4</label>
          <caption>
            <p>Age distribution of broad histological types of head and neck cancer</p>
          </caption>
          <table frame="hsides" rules="groups">
            <tbody>
              <tr>
                <td align="left">
                  <bold>HISTOLOGICAL TYPES</bold>
                </td>
                <td align="center" colspan="5">
                  <bold>AGE GROUP (years)</bold>
                </td>
                <td/>
              </tr>
              <tr>
                <td/>
                <td colspan="6">
                  <hr/>
                </td>
              </tr>
              <tr>
                <td/>
                <td align="center">
                  <bold>1-14</bold>
                </td>
                <td align="center">
                  <bold>15-24</bold>
                </td>
                <td align="center">
                  <bold>25-44</bold>
                </td>
                <td align="center">
                  <bold>45-64</bold>
                </td>
                <td align="center">
                  <bold>&#x2265;65</bold>
                </td>
                <td align="center">
                  <bold>TOTAL</bold>
                </td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Carcinomas</bold>
                </td>
                <td align="center">19(2.2%)</td>
                <td align="center">77(8.8%)</td>
                <td align="center">238(27.2%)</td>
                <td align="center">361(41.4%)</td>
                <td align="center">178(20.4%)</td>
                <td align="center">873*(100%)</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Lymphomas</bold>
                </td>
                <td align="center">46(22%)</td>
                <td align="center">32(15.3%)</td>
                <td align="center">56(26.8%)</td>
                <td align="center">59(28.2%)</td>
                <td align="center">60(28.7%)</td>
                <td align="center">209(100%)</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Sarcomas</bold>
                </td>
                <td align="center">20(18.9%)</td>
                <td align="center">34(32.1%)</td>
                <td align="center">35(33%)</td>
                <td align="center">14(13.2%)</td>
                <td align="center">3(2.8%)</td>
                <td align="center">106(100%)</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Neuroendocrine tumours</bold>
                </td>
                <td align="center">0</td>
                <td align="center">1(50%)</td>
                <td align="center">1(50%)</td>
                <td align="center">0</td>
                <td align="center">0</td>
                <td align="center">2(100%)</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>TOTAL</bold>
                </td>
                <td align="center">85(7.1%)</td>
                <td align="center">144(12.1%)</td>
                <td align="center">330(27.7%)</td>
                <td align="center">434(36.5%)</td>
                <td align="center">197(16.6%)</td>
                <td align="center">1190(100%)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>*Two ages missing</p>
          </table-wrap-foot>
        </table-wrap>
        <p>Grouping the malignant lesions into their broad lineages the mean ages of those with carcinomas, sarcomas, lymphomas and neuroendocrine tumours were 48.1 (SD &#xB1; 17.5), 27.1 (SD &#xB1; 16.7), 35.1 (SD &#xB1; 20.6) and 28.5 (SD &#xB1; 6.4) respectively.</p>
      </sec>
      <sec>
        <title>Topographic distribution of the broad histological types of head and neck cancer</title>
        <p>The predominant anatomical sites for carcinomas were the larynx, nasopharynx, maxillofacial bones and oral cavity, in descending order of frequency (Table <xref ref-type="table" rid="T5">5</xref>). Lymphomas were most frequent in the lymph nodes (39.7%) followed by the maxillofacial bones. By contrast, sarcomas occurred most frequently in the maxillofacial bones (42.5%), face/scalp (17.9%) and the nose (12.3%). Both cases of the neuroendocrine carcinomas occurred in the nose (Table <xref ref-type="table" rid="T5">5</xref>).</p>
        <table-wrap id="T5" position="float">
          <label>Table 5</label>
          <caption>
            <p>Anatomical distribution of broad histological types of head and neck cancer</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left">Histological type</th>
                <th align="center">N</th>
                <th align="center">NP</th>
                <th align="center">OP</th>
                <th align="center">HP</th>
                <th align="center">LRX</th>
                <th align="center">EO</th>
                <th align="center">EAR</th>
                <th align="center">IO</th>
                <th align="center">MB</th>
                <th align="center">F/S</th>
                <th align="center">LN</th>
                <th align="center">SG</th>
                <th align="center">Total</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">
                  <bold>Carcinomas</bold>
                </td>
                <td align="center">93</td>
                <td align="center">164</td>
                <td align="center">9</td>
                <td align="center">6</td>
                <td align="center">172</td>
                <td align="center">7</td>
                <td align="center">14</td>
                <td align="center">125</td>
                <td align="center">144</td>
                <td align="center">40</td>
                <td align="center">41</td>
                <td align="center">60</td>
                <td align="center">875</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Lymphomas</bold>
                </td>
                <td align="center">20</td>
                <td align="center">21</td>
                <td align="center">4</td>
                <td align="center">0</td>
                <td align="center">1</td>
                <td align="center">0</td>
                <td align="center">1</td>
                <td align="center">17</td>
                <td align="center">55</td>
                <td align="center">4</td>
                <td align="center">83</td>
                <td align="center">3</td>
                <td align="center">209</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Sarcomas</bold>
                </td>
                <td align="center">13</td>
                <td align="center">6</td>
                <td align="center">1</td>
                <td align="center">1</td>
                <td align="center">3</td>
                <td align="center">0</td>
                <td align="center">1</td>
                <td align="center">7</td>
                <td align="center">45</td>
                <td align="center">19</td>
                <td align="center">9</td>
                <td align="center">1</td>
                <td align="center">106</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Neuroendocrine</bold>
                </td>
                <td align="center">2</td>
                <td align="center">0</td>
                <td align="center">0</td>
                <td align="center">0</td>
                <td align="center">0</td>
                <td align="center">0</td>
                <td align="center">0</td>
                <td align="center">0</td>
                <td align="center">0</td>
                <td align="center">0</td>
                <td align="center">0</td>
                <td align="center">0</td>
                <td align="center">2</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>TOTAL</bold>
                </td>
                <td align="center">128</td>
                <td align="center">191</td>
                <td align="center">14</td>
                <td align="center">7</td>
                <td align="center">176</td>
                <td align="center">7</td>
                <td align="center">16</td>
                <td align="center">149</td>
                <td align="center">244</td>
                <td align="center">63</td>
                <td align="center">133</td>
                <td align="center">64</td>
                <td align="center">1192</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><underline>KEY</underline> N-Nose, NP-nasopharynx, OP-oropharynx, HP-hypopharynx, LRX-larynx, EO-oesophagus, IO-intraoral, MB-maxillofacial bones, FS-face and scalp, LN-cervical lymph nodes, SG-salivary glands.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Topographic distribution of the broad histological types of head and neck cancer in the maxillofacial area</title>
        <p>Carcinomas and sarcomas of the maxillofacial region were commonest in the maxilla, while the highest number of lymphomas occurred in the mandible (Table <xref ref-type="table" rid="T6">6</xref>). Other common sites for carcinomas were the salivary glands and palate, while the only other common site for sarcomas was the mandible. Lymphomas also occurred in the maxilla and tonsil. The lip was the site least affected by carcinomas, sarcomas and lymphomas. No lesion was indicated as involving the gingiva alone. In addition, no mesenchymal or haematological malignancies were found in the floor of the mouth, as seen in Table <xref ref-type="table" rid="T6">6</xref> below.</p>
        <table-wrap id="T6" position="float">
          <label>Table 6</label>
          <caption>
            <p>Anatomical distribution of broad histological types of head and neck cancer within the maxillofacial region</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left">ANATOMICAL SITE</th>
                <th align="center" colspan="3">HISTOLOGICAL TYPES</th>
                <th align="center">Total</th>
              </tr>
              <tr>
                <th/>
                <th colspan="3">
                  <hr/>
                </th>
                <th/>
              </tr>
              <tr>
                <th/>
                <th align="center">Carcinomas</th>
                <th align="center">Lymphomas</th>
                <th align="center">Sarcomas</th>
                <th/>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">
                  <bold>Palate</bold>
                </td>
                <td align="center">53(17.1%)</td>
                <td align="center">2(2.9%)</td>
                <td align="center">0</td>
                <td align="center">55</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Cheek</bold>
                </td>
                <td align="center">19(6.1%)</td>
                <td align="center">1(1.4%)</td>
                <td align="center">5(9.4%)</td>
                <td align="center">25</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Tongue</bold>
                </td>
                <td align="center">24(7.7%)</td>
                <td align="center">0</td>
                <td align="center">1(1.9%)</td>
                <td align="center">25</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Tonsil</bold>
                </td>
                <td align="center">12(3.9%)</td>
                <td align="center">13(18.6%)</td>
                <td align="center">1(1.9%)</td>
                <td align="center">26</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>FOM</bold>
                </td>
                <td align="center">11(3.5%)</td>
                <td align="center">0</td>
                <td align="center">0</td>
                <td align="center">11</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Lip</bold>
                </td>
                <td align="center">8(2.6%)</td>
                <td align="center">1(1.4%)</td>
                <td align="center">0</td>
                <td align="center">9</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Mandible</bold>
                </td>
                <td align="center">43(13.9%)</td>
                <td align="center">26(37.1%)</td>
                <td align="center">16(30.2%)</td>
                <td align="center">85</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Maxilla</bold>
                </td>
                <td align="center">63(20.3%)</td>
                <td align="center">22(31.4%)</td>
                <td align="center">20(37.7%)</td>
                <td align="center">105</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Salivary glands</bold>
                </td>
                <td align="center">57(18.4%)</td>
                <td align="center">2(2.9%)</td>
                <td align="center">1(1.9%)</td>
                <td align="center">60</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Face</bold>
                </td>
                <td align="center">20(6.5%)</td>
                <td align="center">3(4.3%)</td>
                <td align="center">9(17.0%)</td>
                <td align="center">32</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>TOTAL</bold>
                </td>
                <td align="center">310(100.0%)</td>
                <td align="center">70(100.0%)</td>
                <td align="center">53(100.0%)</td>
                <td align="center">433</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>KEY: FOM- FLOOR OF MOUTH</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>In this 19-year study, the frequency of malignant head and neck neoplasms was 62 cases per year, which is in agreement with a 15 year study of Adeyemi et al [<xref ref-type="bibr" rid="B7">7</xref>] from the same centre. However our figure is higher than previous Nigerian hospital based studies of head and neck cancer, which was reported as 31 cases from Obafemi Awolowo University in Ile-Ife, Nigeria [<xref ref-type="bibr" rid="B14">14</xref>], 47 cases from Jos University Teaching Hospital [<xref ref-type="bibr" rid="B15">15</xref>] and 38 cases from Lagos University Teaching Hospital [<xref ref-type="bibr" rid="B16">16</xref>]. The higher number seen at the University College Hospital, Ibadan could be due to the availability of facilities for multimodality management of head and neck cancer patients in the hospital as compared to some of the other centres [<xref ref-type="bibr" rid="B7">7</xref>].</p>
      <p>A study in North America showed a relatively steady rise in cases of head and neck cancer from 1985-1994 [<xref ref-type="bibr" rid="B17">17</xref>].Our study however showed no regular pattern of increase or decrease in cancer cases. This discrepancy may be due to the failure of patients to present at hospitals in developing countries such as Nigeria because of lack of awareness and or lack of financial resources to cater for conventional medical therapy. An additional factor is the preference of many patients for non-orthodox medical care, which contributes to late presentation or complete lack of presentation, thereby distorting the true epidemiological picture [<xref ref-type="bibr" rid="B18">18</xref>].</p>
      <p>The male to female ratio of 1.9:1 in this study, is in agreement with 1:1 to 2.3:1 reported by Lilly-Tariah <italic>et al </italic>[<xref ref-type="bibr" rid="B19">19</xref>] in which a meta-analysis review of twenty-seven relevant published articles on head and neck cancers in Nigeria from 1968 to 2008 was undertaken. Further supporting findings from the present study, are male: female ratios of 1.7:1 in a six year review by Abuidris <italic>et al </italic>[<xref ref-type="bibr" rid="B20">20</xref>] in central Sudan and a 2.4:1 ratio in a 13 year Japanese study [<xref ref-type="bibr" rid="B21">21</xref>]. Furthermore, a 19 year Chinese study reported a male to female ratio of 2.4:1 [<xref ref-type="bibr" rid="B22">22</xref>]. These studies, which consider all head and neck malignancies together, support a male preponderance but separate consideration of each group of malignant lesions may give a clearer picture of gender distribution.</p>
      <p>The overall age range of 1 year to 98 years in this study is in agreement with the meta-analysis of related Nigerian studies where a range of 9 months to over 80 years was reported [<xref ref-type="bibr" rid="B19">19</xref>]. Head and neck malignancies generally occurred least frequently within the first 14 years of life and displayed a gradual increase until it peaked in the 45-64 years range (36.4%). This peak is slightly higher than the 3<sup>rd </sup>to 6<sup>th </sup>decades (20-59 years) reported by Lilly-Tariah [<xref ref-type="bibr" rid="B19">19</xref>] who included in their study, thyroid and ocular malignancies, which could be relatively high in children. Overall mean age of 43.9 years (SD &#xB1; 19.3) for patients in this study is comparable to 48.8 years reported by Abuidris [<xref ref-type="bibr" rid="B20">20</xref>]. This may have been influenced by the fact that both studies had a large proportion of squamous cell carcinomas, which are known to peak in the 5<sup>th </sup>decade (40-49 years) [<xref ref-type="bibr" rid="B23">23</xref>].</p>
      <p>The general topography in this study indicated that the upper respiratory tract (43.2%) was the most common site affected by head and neck cancers. This finding is similar to a report on the overall pattern of head and neck cancers from different regions of Nigeria, in which nasopharynx, nose and larynx were the three most common sites (in descending order) [<xref ref-type="bibr" rid="B19">19</xref>]. In contrast Amusa <italic>et al </italic>[<xref ref-type="bibr" rid="B14">14</xref>] reported the oral cavity as the most common site in Ile-Ife, Nigeria (south-west) accounting for 36.8% of cases. In this present study however the oral cavity was the third most common site (12.5%) after the maxillofacial bones (20.5%). The reason for the discrepancy between the Ibadan and Ile-Ife study is not clear since both centres are in the South West of Nigeria and are exposed to similar diets and environmental factors. A study performed in central Sudan found the oral cavity to be the fourth most common site (10.5%) after the upper respiratory tract (72.7%) which was the commonest site [<xref ref-type="bibr" rid="B20">20</xref>].</p>
      <p>In an analysis of over 19,400 patients with malignant head and neck tumours in Guangxi province of China, the most frequently involved sites were the nasopharynx followed by the mouth, maxillofacial regions and the neck [<xref ref-type="bibr" rid="B22">22</xref>]. Consumption of preserved food particularly salted fish has been implicated in nasopharyngeal cancer in China [<xref ref-type="bibr" rid="B24">24</xref>]. Findings in this study are in consonance with most other studies concerning the most commonly affected site in head and neck malignancies. Wood smoke in ill-ventilated houses in Africa, wood dust and Epstein Barr virus infection have been suggested as possible predisposing factors in Africans [<xref ref-type="bibr" rid="B25">25</xref>] and may account for the findings in this study.</p>
      <p>Observation in the present study that most of the tumours seen in the 1-14 years age range were lymphomas (54.1%) are similar to the report by Bailey <italic>et al </italic>[<xref ref-type="bibr" rid="B26">26</xref>] which reported lymphomas as constituting 57% of head and neck malignancies in children. Further observation that lymphomas involved mainly the lymph nodes (39.7%), is consistent with the report of Hoffman <italic>et al </italic>[<xref ref-type="bibr" rid="B17">17</xref>] who also found that lymph nodes of the head and neck were the most common sites for lymphomas.</p>
      <p>Sarcomas of the head and neck had an overall male: female ratio of 1.5:1. This finding is similar to the 1.3:1 male: female ratio reported by Adebayo <italic>et al </italic>[<xref ref-type="bibr" rid="B27">27</xref>] in Kaduna state, Nigeria. However the Memorial Sloan-Kettering Cancer Centre study [<xref ref-type="bibr" rid="B28">28</xref>] reported a male: female ratio of about 1:1.</p>
      <p>The neuroendocrine malignancies seen in this study had a male: female ratio of 1:1, which agrees with the male: female of 1:1 reported in a study by Monroe <italic>et al </italic>[<xref ref-type="bibr" rid="B29">29</xref>] and is close to the 1.3:1 reported in a study in the USA [<xref ref-type="bibr" rid="B30">30</xref>]. However, it is at variance with the female to male ratio of 2.3:1 observed by Castelnuovo <italic>et al </italic>[<xref ref-type="bibr" rid="B31">31</xref>]. It is pertinent to mention that neuroendocrine carcinomas are rare.</p>
      <p>Separate consideration of the oro-facial complex (maxillofacial bones and oral cavity) in this study found that the most common sites were the maxilla (24.3%), mandible (19.7%) and salivary glands (13.9%). Intraorally, the palate was the most common site (12.7%) followed by the tonsils and the cheek. This is in agreement with findings by Lawoyin <italic>et al </italic>[<xref ref-type="bibr" rid="B32">32</xref>], also from Ibadan, who reported that the palate was the most common intraoral site, but is at variance with a report by Odukoya <italic>et al </italic>[<xref ref-type="bibr" rid="B33">33</xref>] from Lagos in which the mandibular gingiva, maxillary gingiva and hard palate were the most common intraoral sites (in descending order). Other studies from Nigeria showed the tongue, palate and mandibular alveolus as the most commonly affected sites (in descending order) [<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. In South East Asia, the buccal mucosa and retromolar areas were the most prone areas [<xref ref-type="bibr" rid="B36">36</xref>]. Ugboko <italic>et al </italic>[<xref ref-type="bibr" rid="B37">37</xref>] from Ile-Ife, Nigeria reported the alveolus (29.6%) as the most common intraoral site. It is our thought that malignant lesions which may have originated in the gingiva and subsequently invaded the alveolus of patients in our study were diagnosed as maxillary or mandibular cancers, due to late presentation.</p>
      <p>The broad histological types of malignancies in the present study were carcinomas (73.4%), lymphomas (17.5%), sarcomas (8.9%) and neuroendocrine tumours (0.2%). This contrasted favourably with findings by Adeyemi <italic>et al </italic>[<xref ref-type="bibr" rid="B7">7</xref>] that reported carcinomas (71.7%), lymphomas (20.4%) and sarcomas (7.9%) to be the major categories. Another study in Plateau state, Nigeria found that carcinomas predominated over sarcomas with lymphomas featuring in between [<xref ref-type="bibr" rid="B38">38</xref>]. In contrast Amusa <italic>et al </italic>[<xref ref-type="bibr" rid="B14">14</xref>] in a ten year review on the pattern of head and neck malignant tumours reported lymphomas (40.3%) as the predominant histological type followed by squamous cell carcinomas (25.3%), sarcomas (2.6%) and other minor variants (31.9%). The consideration of squamous cell carcinoma as the only epithelial malignancy in their study may have resulted in the perceptible dominance of lymphomas.</p>
      <p>In the National Cancer Data Base, which is limited to 50 states and the District of Columbia, United States of America, Hoffman [<xref ref-type="bibr" rid="B17">17</xref>] reported 295,022 cases of head and neck cancers of which carcinomas accounted for 75.2% while lymphomas constituted 15.1%. This result is also similar to the present study except that the criteria for inclusion of cancers vary and lesions like sarcomas and neuroendocrine tumours were not clearly specified.</p>
      <p>It was noted in this study that carcinomas increased in incidence while lymphomas reduced from 2002-2008. A report by the Surveillance Epidemiology and End Results [<xref ref-type="bibr" rid="B39">39</xref>] programme noted a slight gradual increase when all head and neck cancers are considered together from 1985-2005 [<xref ref-type="bibr" rid="B39">39</xref>]. The increase in carcinomas noted in the present study may be due to the increasing incidence of head and neck cancers in women consequent to an increasing exposure to risk factors [<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B41">41</xref>], while the decrease in lymphomas may actually reflect the decreasing incidence of Burkitt's lymphoma in Nigeria which may be ascribed to improved living conditions and better management of malaria [<xref ref-type="bibr" rid="B42">42</xref>].</p>
      <p>From the 1192 malignant cases of head and neck malignant tumours investigated in this study, 142 (11.9%) were poorly differentiated/undifferentiated while the remaining 1050 (88.1%) were differentiated, giving a ratio of undifferentiated to differentiated tumours in this study as 1:7.4, which is higher than 1:9 computed from the study by Vege <italic>et al </italic>[<xref ref-type="bibr" rid="B43">43</xref>]. Relatively higher prevalence of poorly differentiated cancers in Africans has been reported [<xref ref-type="bibr" rid="B44">44</xref>].</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>The clinico-pathological summary of head and neck malignancies in western Nigeria is not different from profiles in other parts of the world. Malignancies of epithelial lineage are more common than other lineages in the head and neck whereas neuroendocrine tumours of the head and neck are rare. It is expedient to conduct this sort of study periodically to monitor the changing trends of head and neck cancer so that apt attention can be accorded the predominant type and changes can be investigated to know if a new carcinogen has been introduced to the environment.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>'The author(s) declare that they have no competing interests'</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>AO, AO and JO were involved in the conception and design of the study. AO acquired the data. AO and BF participated in the analysis and interpretation of the data. BF, EEU and B were involved in drafting the manuscript. AO and EEU revised the manuscript. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="book">
          <name>
            <surname>Barnes</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Eveson</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Reichart</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
          <article-title>World Health Organization classification of tumours</article-title>
          <source>Pathology and genetics of tumours of the head and neck</source>
          <year>2005</year>
          <publisher-name>Lyon: IARC Press</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Onakoya</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Nwaorgu</surname>
            <given-names>OG</given-names>
          </name>
          <name>
            <surname>Adenipekun</surname>
            <given-names>AO</given-names>
          </name>
          <etal/>
          <article-title>Quality of life in patients with head and neck cancers</article-title>
          <source>J Natl Med Assoc</source>
          <year>2006</year>
          <volume>98</volume>
          <issue>5</issue>
          <fpage>765</fpage>
          <lpage>770</lpage>
          <pub-id pub-id-type="pmid">16749653</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Goldenberg</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Koch</surname>
            <given-names>WM</given-names>
          </name>
          <etal/>
          <article-title>Habitual risk factors for head and neck cancer</article-title>
          <source>Otolaryngol Head Neck Surg</source>
          <year>2004</year>
          <volume>131</volume>
          <issue>6</issue>
          <fpage>986</fpage>
          <lpage>993</lpage>
          <pub-id pub-id-type="doi">10.1016/j.otohns.2004.02.035</pub-id>
          <pub-id pub-id-type="pmid">15577802</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fan</surname>
            <given-names>CY</given-names>
          </name>
          <article-title>Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications</article-title>
          <source>Curr Oncol Rep</source>
          <year>2004</year>
          <volume>6</volume>
          <fpage>152</fpage>
          <lpage>161</lpage>
          <pub-id pub-id-type="doi">10.1007/s11912-004-0027-0</pub-id>
          <pub-id pub-id-type="pmid">14751093</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ringstr&#xF6;m</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Peters</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Hasegawa</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
          <article-title>Molecular oncology, markers, clinical correlates. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck</article-title>
          <source>Clin Cancer Res</source>
          <year>2002</year>
          <volume>8</volume>
          <fpage>3187</fpage>
          <lpage>3192</lpage>
          <pub-id pub-id-type="pmid">12374687</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Semple</surname>
            <given-names>CJ</given-names>
          </name>
          <article-title>The role of the CNS in head and neck oncology</article-title>
          <source>Nurs Stand</source>
          <year>2001</year>
          <volume>15</volume>
          <issue>31</issue>
          <fpage>39</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">12211936</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Adeyemi</surname>
            <given-names>BF</given-names>
          </name>
          <name>
            <surname>Adekunle</surname>
            <given-names>LV</given-names>
          </name>
          <name>
            <surname>Kolude</surname>
            <given-names>BM</given-names>
          </name>
          <name>
            <surname>Akang</surname>
            <given-names>EEU</given-names>
          </name>
          <name>
            <surname>Lawoyin</surname>
            <given-names>JO</given-names>
          </name>
          <article-title>Head and neck cancer - a clinicopathological study in a tertiary care centre</article-title>
          <source>J Natl Med Assoc</source>
          <year>2008</year>
          <volume>100</volume>
          <fpage>690</fpage>
          <lpage>697</lpage>
          <pub-id pub-id-type="pmid">18595571</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ologe</surname>
            <given-names>FE</given-names>
          </name>
          <name>
            <surname>Adeniji</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Segun-Busari</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Clinicopathological study of head and neck cancers in Ilorin, Nigeria</article-title>
          <source>Trop Doct</source>
          <year>2005</year>
          <volume>35</volume>
          <issue>1</issue>
          <fpage>2</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1258/0049475053001949</pub-id>
          <pub-id pub-id-type="pmid">15712528</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dubey</surname>
            <given-names>SP</given-names>
          </name>
          <name>
            <surname>Sengupta</surname>
            <given-names>SK</given-names>
          </name>
          <name>
            <surname>Kaleh</surname>
            <given-names>LK</given-names>
          </name>
          <name>
            <surname>Morewaya</surname>
            <given-names>JT</given-names>
          </name>
          <article-title>Adult head and neck lymphomas in Papua New Guinea: a retrospective study of 70 cases</article-title>
          <source>J Surg</source>
          <year>1999</year>
          <volume>69</volume>
          <issue>11</issue>
          <fpage>778</fpage>
          <lpage>781</lpage>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="other">
          <name>
            <surname>McMains</surname>
            <given-names>CK</given-names>
          </name>
          <name>
            <surname>Gourin</surname>
            <given-names>CG</given-names>
          </name>
          <article-title>Pathology: Sarcomas of the head and neck</article-title>
          <source>Emedicine</source>
          <year>2007</year>
          <ext-link ext-link-type="uri" xlink:href="http://www.emedicine.com/ent/topic675.htm">http://www.emedicine.com/ent/topic675.htm</ext-link>
          <comment>Accessed on 9/08/2008</comment>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sturgis</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Potter</surname>
            <given-names>BO</given-names>
          </name>
          <article-title>Sarcomas of the head and neck region</article-title>
          <source>Curr Opin Oncol</source>
          <year>2003</year>
          <volume>15</volume>
          <issue>3</issue>
          <fpage>239</fpage>
          <lpage>252</lpage>
          <pub-id pub-id-type="doi">10.1097/00001622-200305000-00011</pub-id>
          <pub-id pub-id-type="pmid">12778019</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pivota</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Niyikizab</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Poissonneta</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
          <article-title>Clinical prognostic factors for patients with recurrent head and neck cancer: implications for randomized trials</article-title>
          <source>Oncology</source>
          <year>2001</year>
          <volume>61</volume>
          <issue>3</issue>
          <fpage>197</fpage>
          <lpage>204</lpage>
          <pub-id pub-id-type="doi">10.1159/000055375</pub-id>
          <pub-id pub-id-type="pmid">11574775</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="book">
          <collab>Department Of International Economic and Social Affairs</collab>
          <source>Provisional guidelines on standard international age classifications</source>
          <year>1982</year>
          <publisher-name>New York</publisher-name>
          <comment>Statistical Papers Office series M No.74 United Nations</comment>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Amusa</surname>
            <given-names>YB</given-names>
          </name>
          <name>
            <surname>Olabanji</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Akinpelu</surname>
            <given-names>VO</given-names>
          </name>
          <name>
            <surname>Olateju</surname>
            <given-names>SO</given-names>
          </name>
          <name>
            <surname>Agbakwuru</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Ndukwe</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Fatusi</surname>
            <given-names>OA</given-names>
          </name>
          <name>
            <surname>Ojo</surname>
            <given-names>OS</given-names>
          </name>
          <article-title>Pattern of head and neck malignant tumours in a Nigerian teaching hospital--a ten year review</article-title>
          <source>West Afr J Med</source>
          <year>2004</year>
          <volume>23</volume>
          <issue>4</issue>
          <fpage>280</fpage>
          <lpage>285</lpage>
          <pub-id pub-id-type="pmid">15730084</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Otoh</surname>
            <given-names>EC</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>NW</given-names>
          </name>
          <name>
            <surname>Mandong</surname>
            <given-names>BM</given-names>
          </name>
          <name>
            <surname>Danfillo</surname>
            <given-names>IS</given-names>
          </name>
          <article-title>Primary head and neck cancers in Jos, Nigeria: a re-visit</article-title>
          <source>West Afr J Med</source>
          <year>2006</year>
          <volume>25</volume>
          <issue>2</issue>
          <fpage>92</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="pmid">16918178</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="other">
          <name>
            <surname>Nwawolo</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Ajekigbe</surname>
            <given-names>AT</given-names>
          </name>
          <name>
            <surname>Oyeneyin</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Nwankwo</surname>
            <given-names>KC</given-names>
          </name>
          <name>
            <surname>Okeowo</surname>
            <given-names>PA</given-names>
          </name>
          <article-title>Pattern of head and neck cancers among Nigerians in Lagos</article-title>
          <source>West Afr J Med</source>
          <year>2001</year>
          <issue>2</issue>
          <fpage>111</fpage>
          <lpage>116</lpage>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hoffman</surname>
            <given-names>HT</given-names>
          </name>
          <name>
            <surname>Karnell</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>Funk</surname>
            <given-names>GF</given-names>
          </name>
          <name>
            <surname>Robinson</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Menck</surname>
            <given-names>HR</given-names>
          </name>
          <article-title>The National Cancer Data Base report on cancer of the head and neck</article-title>
          <source>Arch Otolaryngol Head Neck Surg</source>
          <year>1998</year>
          <volume>124</volume>
          <issue>9</issue>
          <fpage>951</fpage>
          <lpage>962</lpage>
          <pub-id pub-id-type="pmid">9738803</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tovey</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Broom</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chatwin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hafeez</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ahmad</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Patient assessment of effectiveness and satisfaction with traditional medicine, globalized complementary and alternative medicines, and allopathic medicines for cancer in Pakistan</article-title>
          <source>Integr Cancer Ther</source>
          <year>2005</year>
          <volume>4</volume>
          <issue>3</issue>
          <fpage>242</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="doi">10.1177/1534735405279600</pub-id>
          <pub-id pub-id-type="pmid">16113032</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lilly-Tariah</surname>
            <given-names>OB</given-names>
          </name>
          <name>
            <surname>Somefun</surname>
            <given-names>AO</given-names>
          </name>
          <name>
            <surname>Adeyemo</surname>
            <given-names>WL</given-names>
          </name>
          <article-title>Current evidence on the burden of head and neck cancers in Nigeria</article-title>
          <source>Head Neck Oncol</source>
          <year>2009</year>
          <volume>1</volume>
          <issue>14</issue>
          <fpage>1</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">19284679</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Abuidris</surname>
            <given-names>DO</given-names>
          </name>
          <name>
            <surname>Elhaj</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Eltayeb</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Elgayli</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Mustafa</surname>
            <given-names>OM</given-names>
          </name>
          <article-title>Pattern of head and neck malignancies in Central Sudan- (study of 314 cases)</article-title>
          <source>Sudan J Med Sci</source>
          <year>2008</year>
          <volume>3</volume>
          <issue>2</issue>
          <fpage>105</fpage>
          <lpage>108</lpage>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Takahiro</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Satoshi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Masahiro</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Katsuro</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sugata</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Fumio</surname>
            <given-names>I</given-names>
          </name>
          <article-title>Head and neck malignant tumours in Niigata prefecture- the first report: demographics in 4,053 cases</article-title>
          <source>J Otolaryngol Jap</source>
          <year>2003</year>
          <volume>106</volume>
          <issue>2</issue>
          <fpage>164</fpage>
          <lpage>172</lpage>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Anyu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Xuedong</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Long</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
          <article-title>Analysis of 26,826 patients with tumours in the head and neck</article-title>
          <source>Chinese J Cancer Res</source>
          <year>1993</year>
          <volume>5</volume>
          <issue>2</issue>
          <fpage>153</fpage>
          <lpage>156</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02997609</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kurtulmaz</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Erkal</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Serin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Elhan</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Cakmak</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Squamous cell carcinomas of the head and neck: descriptive analysis of 1293 cases</article-title>
          <source>J Laryngol Otol</source>
          <year>1997</year>
          <volume>111</volume>
          <issue>6</issue>
          <fpage>531</fpage>
          <lpage>535</lpage>
          <pub-id pub-id-type="pmid">9231086</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ning</surname>
            <given-names>JP</given-names>
          </name>
          <article-title>Consumption of salted fish and other risk factors for nasopharyngeal carcinoma (NPC) in Tianjin, a low-risk region for NPC in the People's Republic of China</article-title>
          <source>J Natl Cancer Inst</source>
          <year>1990</year>
          <volume>82</volume>
          <issue>4</issue>
          <fpage>291</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="doi">10.1093/jnci/82.4.291</pub-id>
          <pub-id pub-id-type="pmid">2299678</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Clifford</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bulbrook</surname>
            <given-names>RD</given-names>
          </name>
          <article-title>Environmental studies in African males in nasopharyngeal carcinoma</article-title>
          <source>Lancet</source>
          <year>1967</year>
          <volume>1</volume>
          <fpage>1228</fpage>
          <pub-id pub-id-type="pmid">4165148</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="other">
          <name>
            <surname>Bailey</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Newlands</surname>
            <given-names>SD</given-names>
          </name>
          <article-title>Paediatric malignancies</article-title>
          <source>Head and Neck Surgery - Otolaryngology</source>
          <fpage>1358</fpage>
          <lpage>1360</lpage>
          <comment>Chapter 98</comment>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Adebayo</surname>
            <given-names>ET</given-names>
          </name>
          <name>
            <surname>Ajike</surname>
            <given-names>SO</given-names>
          </name>
          <name>
            <surname>Adebola</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Maxillofacial sarcomas in Nigeria</article-title>
          <source>Ann Afr Med</source>
          <year>2005</year>
          <volume>4</volume>
          <issue>1</issue>
          <fpage>23</fpage>
          <lpage>30</lpage>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bentz</surname>
            <given-names>BG</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Woodruff</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Brennan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Shah</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Kraus</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Head and neck soft tissue sarcomas: a multivariate analysis of outcomes</article-title>
          <source>Ann Surg Oncol</source>
          <year>1972</year>
          <volume>11</volume>
          <issue>6</issue>
          <fpage>619</fpage>
          <lpage>628</lpage>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Monroe</surname>
            <given-names>AT</given-names>
          </name>
          <name>
            <surname>Hinerman</surname>
            <given-names>RW</given-names>
          </name>
          <name>
            <surname>Amdur</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Mendenhall</surname>
            <given-names>WM</given-names>
          </name>
          <article-title>Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation</article-title>
          <source>Head Neck</source>
          <year>2003</year>
          <volume>25</volume>
          <issue>7</issue>
          <fpage>529</fpage>
          <lpage>534</lpage>
          <pub-id pub-id-type="doi">10.1002/hed.10247</pub-id>
          <pub-id pub-id-type="pmid">12808655</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Devaiah</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Larsen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tawfik</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>O'Boynick</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Hoover</surname>
            <given-names>LA</given-names>
          </name>
          <article-title>Esthesioneuroblastoma: endoscopic nasal and anterior craniotomy resection</article-title>
          <source>Laryngoscope</source>
          <year>2003</year>
          <volume>113</volume>
          <issue>12</issue>
          <fpage>2086</fpage>
          <lpage>2090</lpage>
          <pub-id pub-id-type="doi">10.1097/00005537-200312000-00005</pub-id>
          <pub-id pub-id-type="pmid">14660907</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Castelnuovo</surname>
            <given-names>PG</given-names>
          </name>
          <name>
            <surname>Del&#xF9;</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sberze</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
          <article-title>Esthesioneuroblastoma: Endonasal endoscopic treatment</article-title>
          <source>Skull Base</source>
          <year>2006</year>
          <volume>16</volume>
          <issue>1</issue>
          <fpage>25</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1055/s-2005-922097</pub-id>
          <pub-id pub-id-type="pmid">16880898</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lawoyin</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Lawoyin</surname>
            <given-names>DO</given-names>
          </name>
          <name>
            <surname>Aderinokun</surname>
            <given-names>GO</given-names>
          </name>
          <article-title>Intraoral squamous cell carcinoma in Ibadan: A review of 90 cases</article-title>
          <source>Afr J Med Med Sci</source>
          <year>1997</year>
          <volume>26</volume>
          <issue>3-4</issue>
          <fpage>187</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">10456168</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Odukoya</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Mosadomi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sawyer</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Squamous cell carcinoma of the oral cavity. A clinicopathological study of 106 Nigerian cases</article-title>
          <source>J Maxillofac Surg</source>
          <year>1986</year>
          <volume>14</volume>
          <fpage>267</fpage>
          <lpage>269</lpage>
          <pub-id pub-id-type="pmid">3464681</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Arotiba</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Obiechina</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Fasola</surname>
            <given-names>OA</given-names>
          </name>
          <name>
            <surname>Ajagbe</surname>
            <given-names>HA</given-names>
          </name>
          <article-title>Oral squamous cell carcinoma: A review of 246 Nigerian cases</article-title>
          <source>Afr J Med Med Sci</source>
          <year>1999</year>
          <volume>28</volume>
          <issue>3-4</issue>
          <fpage>141</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="pmid">11205818</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Daramola</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Ajagbe</surname>
            <given-names>HA</given-names>
          </name>
          <name>
            <surname>Oluwasanmi</surname>
            <given-names>JO</given-names>
          </name>
          <article-title>Pattern of oral cancer in a Nigerian population</article-title>
          <source>Br J Oral Surg</source>
          <year>1979</year>
          <volume>17</volume>
          <issue>2</issue>
          <fpage>123</fpage>
          <lpage>128</lpage>
          <pub-id pub-id-type="doi">10.1016/S0007-117X(79)80039-6</pub-id>
          <pub-id pub-id-type="pmid">298836</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Johnson</surname>
            <given-names>NW</given-names>
          </name>
          <article-title>Orofacial neoplasms: Global epidemiology, risk factors and recommendations for research</article-title>
          <source>Int Dent J</source>
          <year>1991</year>
          <volume>41</volume>
          <issue>6</issue>
          <fpage>365</fpage>
          <lpage>375</lpage>
          <pub-id pub-id-type="pmid">1800387</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="other">
          <name>
            <surname>Ugboko</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Ajike</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Olasoji</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Pindiga</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Adebiyi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Omoniyi-Esan</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ayanbadejo</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Primary orofacial squamous cell carcinoma: a multicentre Nigerian study</article-title>
          <source>Internet J Dental Sci</source>
          <year>2004</year>
          <issue>1</issue>
          <fpage>2</fpage>
        </mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bhatia</surname>
            <given-names>PL</given-names>
          </name>
          <article-title>Head and neck cancer in Plateau state of Nigeria</article-title>
          <source>West Afr J Med</source>
          <year>1990</year>
          <volume>9</volume>
          <issue>4</issue>
          <fpage>304</fpage>
          <lpage>310</lpage>
          <pub-id pub-id-type="pmid">2083210</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="other">
          <collab>Surveillance, Epidemiology and End Results (SEER) Program and the National Centre for Health Statistics</collab>
          <article-title>A snapshot of head and neck cancers</article-title>
          <ext-link ext-link-type="uri" xlink:href="http://www.cancer.gov/aboutnci/servingpeople/headandneck-snapshot.pdf">http://www.cancer.gov/aboutnci/servingpeople/headandneck-snapshot.pdf</ext-link>
          <comment>(Accessed on 17/07/2009)</comment>
        </mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pinhort</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Rindum</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pindborg</surname>
            <given-names>JJ</given-names>
          </name>
          <article-title>Oral cancer: a retrospective study of 100 Danish cases</article-title>
          <source>Br J Oral Maxillofac Surg</source>
          <year>1997</year>
          <volume>35</volume>
          <issue>2</issue>
          <fpage>77</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1016/S0266-4356(97)90679-3</pub-id>
          <pub-id pub-id-type="pmid">9146862</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Oliver</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Helfric</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Gard</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Primary oral squamous cell carcinoma: a review of 92 cases</article-title>
          <source>J Oral Maxillofac Surg</source>
          <year>1996</year>
          <volume>54</volume>
          <issue>8</issue>
          <fpage>949</fpage>
          <lpage>954</lpage>
          <pub-id pub-id-type="doi">10.1016/S0278-2391(96)90389-4</pub-id>
          <pub-id pub-id-type="pmid">8765383</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ojesina</surname>
            <given-names>AI</given-names>
          </name>
          <name>
            <surname>Akang</surname>
            <given-names>EEU</given-names>
          </name>
          <name>
            <surname>Ojemakinde</surname>
            <given-names>KO</given-names>
          </name>
          <article-title>Decline in the frequency of Burkitt's lymphoma relative to other childhood malignancies in Ibadan, Nigeria</article-title>
          <source>Ann Trop Pediatr</source>
          <year>2002</year>
          <volume>22</volume>
          <issue>2</issue>
          <fpage>159</fpage>
          <lpage>163</lpage>
          <pub-id pub-id-type="doi">10.1179/027249302125000887</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Vege</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Soman</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Joshi</surname>
            <given-names>UA</given-names>
          </name>
          <name>
            <surname>Ganesh</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Yadav</surname>
            <given-names>JN</given-names>
          </name>
          <article-title>Undifferentiated tumours: an immunohistochemical analysis on biopsies</article-title>
          <source>J Surg Oncol</source>
          <year>1994</year>
          <volume>57</volume>
          <issue>4</issue>
          <fpage>273</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="doi">10.1002/jso.2930570414</pub-id>
          <pub-id pub-id-type="pmid">7990486</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mathur</surname>
            <given-names>SJ</given-names>
          </name>
          <article-title>Epidemiological and etiological factors associated with nasopharyngeal carcinoma</article-title>
          <source>ICMR</source>
          <year>2003</year>
          <volume>39</volume>
          <issue>9</issue>
          <fpage>1</fpage>
          <lpage>9</lpage>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
